RxDoctor Payments Data

Cort Thompson

Physician Assistant · Pismo Beach, CANPI 1639640782

Payments from drug & device makers

$5,782in general payments, 2019–2025

Across 269 payments — averaging $21.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$717
  • GSK$637
  • Novo Nordisk$472
  • Amgen$356
  • Johnson & Johnson$325
  • plus $2K from 22 others

What the payments were for

  • Food & beverage$5,71599%
  • Education$671%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,782 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter118$91,224
OzempicSemaglutide65$83,243
JardianceEmpagliflozin67$72,204
EliquisApixaban43$50,368
FarxigaDapagliflozin Propanediol30$34,076
MounjaroTirzepatide26$33,739
KerendiaFinerenone27$28,023
TrulicityDulaglutide25$26,358
ProliaDenosumab14$24,126
JanuviaSitagliptin Phosphate14$22,502
XareltoRivaroxaban21$21,289
TradjentaLinagliptin31$21,143
Tresiba Flextouch U-200Insulin Degludec12$6,881
Atorvastatin Calcium408$5,085
Budesonide13$3,950

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$73$93,34698 claims
GSKTrelegy Ellipta$637$91,224118 claims
Novo NordiskOzempic$472$83,24365 claims
Lilly USA, LLCMounjaro, Trulicity$271$60,09751 claims
PfizerEliquis$229$50,36843 claims
AstraZenecaFarxiga$717$34,07630 claims
BayerKerendia$82$28,02327 claims
AmgenProlia$356$24,12614 claims
MerckJanuvia$72$22,50214 claims
Johnson & JohnsonXarelto$325$21,28921 claims
AbbVieSynthroid$1,394$2,08921 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Pismo Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →